Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) With Higher-Dose Gleevec (STI571).
Phase of Trial: Phase II
Latest Information Update: 06 Dec 2016
At a glance
- Drugs Imatinib (Primary) ; Cytarabine; Interferon alpha
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 06 Dec 2016 Results from this and other five studies presented at the 58th Annual Meeting and Exposition of the American Society of Hematology.
- 02 Jun 2015 Propensity score analysis using pooled analysis, results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 26 Nov 2013 New source identified and integrated (M.D. Anderson Cancer Center record: ID01-151).